Development of paclitaxel-loaded liposomal systems with anti-her2 antibody for targeted therapy

Creative Commons License

BÜYÜKKÖROĞLU G., ŞENEL B., BAŞARAN E., Gezgin S.

TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, vol.15, no.5, pp.895-903, 2016 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 15 Issue: 5
  • Publication Date: 2016
  • Doi Number: 10.4314/tjpr.v15i5.1
  • Journal Name: TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.895-903
  • Keywords: Cancer, Anti-her2 antibody, Liposome, Paclitaxel, Targeted therapy, Cell culture, SOLID LIPID NANOPARTICLES, MONOCLONAL-ANTIBODY, DELIVERY, CANCER, PLUS
  • Open Archive Collection: AVESIS Open Access Collection
  • Anadolu University Affiliated: Yes

Abstract

Purpose: To develop liposome formulations containing monoclonal antibody anti-HER2 (MabHer2), and Paclitaxel (PTX).